Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.
Press releases published on August 4, 2025
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Transplant Pancreatic …
“Hail and Farewell” Ceremony Honors Incoming Fellows and Graduating Class of 2024–25 at Steadman Philippon Research Institute and The Steadman Clinic
VAIL, Colo., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Each July, Steadman Philippon Research Institute (SPRI) and The Steadman Clinic pause to honor a time-honored tradition—celebrating the accomplishments of outgoing fellows while embracing the arrival of a new …
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
BERKELEY, Calif. and MAINZ, Germany, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the pricing of …
Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction
www.freyapharmasolutions.com Study evaluates Lybrido™’s Dual-Action therapy for Female Sexual Dysfunction Innovative clitoral blood flow measurement technique aims to objectively quantify treatment efficacy of two dose-combinations ALETTA Pivotal Study …
PracticeLink Announces Strategic Partnership with 3RNET
ST. LOUIS and HINTON, West Virginia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- PracticeLink, the nation’s most trusted physician recruitment resource and home of the most widely used online physician job board, is pleased to announce a strategic partnership with …
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models
MENLO PARK, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the results of a study published in Nature Methods describing a new, comprehensive truth- …
Capsa Healthcare Acquires BlueBin to Advance Intelligent Clinical Supply Management
COLUMBUS, Ohio, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leader in healthcare workflow and supply management solutions, today announced the acquisition of BlueBin, a recognized innovator in Kanban-based supply chain systems and predictive …
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
Primary focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates positive signs of both no significant toxicity and superior PFS and …
NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer
CALABASAS, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi-phase 2 clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, was featured on …
Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer
Sonnet's lead product, SON-1010 (IL12-FHAB), is being evaluated in combination with atezolizumab (Tecentriq®) in patients with advanced platinum-resistant ovarian cancer (PROC) (SB221) Topline safety, cytokine, and efficacy data suggest a strong potential …
Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program
70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three major barriers to bending the obesity curve in the US: …
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Dallan Murray as Chief Commercial Officer, effective …
Oral Care Market to Hit $53.29 Billion by 2030 | 6.4% CAGR Growth Forecast | MarketsandMarkets™.
Delray Beach, FL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The global oral care market, valued at US$34.97 billion in 2024 stood at US$37.21 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted …
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency from baseline, with 22% at 100% seizure reduction in last 28 days Initiated two registrational studies for …
MaxCyte Signs Platform License Agreement with Adicet Bio
MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of Adicet’s gamma delta T cell therapy gene edited programs ROCKVILLE, Md., Aug. 04, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering …
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointment of …
Full Alliance Group Launches QUBEE HIVE HOLDINGS to Advance Global Web3 Financial Infrastructure
TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) today announced the formation of QUBEE HIVE HOLDINGS, INC. (“QUBEE HIVE”), a new subsidiary under Qubitera Holdings, Inc., established to accelerate the Company's global …